To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Participation

Clinical Research Enrollment Demand

Clinical Research Enrollment Demand Feature Image

Editor's Note: Rahlyn Gossen is the founder and principal of Rebar Interactive, a digital patient engagement and recruitment company serving clinical trial sponsors and research sites. Prior to founding Rebar, Rahlyn was a clinical research coordinator. Her observations as a coordinator greatly influence her perspective on clinical trials as well as Rebar’s technology products and services, which aim to reduce inefficiency and improve the patient experience. Rahlyn frequently writes and speaks about clinical trial innovation and is on the editorial advisory board for Applied Clinical Trials.

rahlyn photo

Of the challenges in clinical research, participant enrollment remains one of the biggest. According to the Tufts Center for the Study of Drug Development, clinical trial enrollment typically ends up taking two-times longer than planned. These delays drive up the costs to develop new treatments and hinder medical advancement.

Often, the discussion about enrollment delays focuses on supply challenges, such as how patients learn about clinical trials and what helps or hinders them from participating in clinical research. But understanding enrollment demand is equally important to this equation. In order to work toward an enrollment target, we must first know what target we’d like to hit. With this target in mind, we’re in a better position to figure out the steps needed to achieve it. And that brings us to this question: how many people are needed for currently enrolling research studies? 

What did we learn? At the time of this blog post’s publication, the data show that:

  1. Enrollment demand is huge. We need many people to participate in clinical research—to the tune of over 57 million.
  2. Demand for people to enroll in studies is not distributed equally across diseases or phases. For example, nearly half of the enrollment need for cardiovascular disease is in Phase 4 studies.

Take a look to see for yourself! What do you find interesting? Any insights you’d like to share? Tell us what you think by @-mentioning us on Twitter.

ClinicalResearchEnrollmentDemand Infographic 1Aug2019-01

Blog post originally appeared on LillyPad.

Tags: Infographic,

Recent Articles

AHerosJourneyThroughClinicalTrials2-14-2020

A Hero’s Journey Through Clinical Trials

Leigh Anne Naas Headshot
Leigh Anne Naas
February 14th, 20203 minute read

In collaboration with artist John Magnan, we launched a crowd-sourced art project dedicated to clinical trial participants.

InternationalDayofWomenandGirlsinScience FeatureImage 10Feb2020

A STEM Career in Clinical Research

Ayana Rowley Henderson Headshot
Ayana Rowley Henderson
February 11th, 20205 minute read

Read this spotlight on MaryAnn Morgan Cox to learn more about how women in STEM are making a difference.

WhatisClinicalTrials.gov FeatureImage 9Jan2020-01

Infographic: What is ClinicalTrials.gov?

Ayana Rowley Henderson Headshot
Ayana Rowley Henderson
February 4th, 20204 minute read

2020 marks the 20th anniversary of the site, but what were the site's origins and intentions?

BackToSchool Protocol FeatureImage 27Aug2019-01

What is a Protocol in Clinical Trials?

Susan Gilchrist headshot square
Susan Gilchrist
December 10th, 20195 minute read

Have you ever wondered how schedules, tests, and the information ever comes together in clinical trial? It all starts with a clinical trial protocol.

SCRSInterviewBlog FeatureImage 27Nov2019

Clinical Trials 2020 trends, as told by #SCRS19

BlogAuthor Don2 3Dec2019
Don Harder
December 5th, 20197 minute read

After attending SCRS19, four key insights emerged for clinical trials in 2020 and beyond.